PortfoliosLab logoPortfoliosLab logo
MEDP vs. FNV
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MEDP vs. FNV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Medpace Holdings, Inc. (MEDP) and Franco-Nevada Corporation (FNV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MEDP achieves a -18.47% return, which is significantly lower than FNV's 3.78% return.


MEDP

1D
0.80%
1M
8.00%
YTD
-18.47%
6M
-16.62%
1Y
54.44%
3Y*
30.12%
5Y*
21.82%
10Y*

FNV

1D
-1.82%
1M
-7.48%
YTD
3.78%
6M
7.92%
1Y
29.43%
3Y*
14.93%
5Y*
7.95%
10Y*
12.94%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MEDP vs. FNV - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MEDP
Medpace Holdings, Inc.
-18.47%69.05%8.38%44.31%-2.40%56.35%65.60%58.81%45.97%0.53%
FNV
Franco-Nevada Corporation
3.78%77.81%7.41%-17.96%-0.39%11.57%22.31%48.92%-11.00%35.45%

Correlation

The correlation between MEDP and FNV is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (5Y)
Calculated over the trailing 5-year period

0.19

Correlation (All Time)
Calculated using the full available price history since Aug 12, 2016

0.11

Fundamentals

Market Cap

MEDP:

$13.26B

FNV:

$41.49B

EPS

MEDP:

$15.63

FNV:

$7.10

PE Ratio

MEDP:

29.29

FNV:

30.25

PEG Ratio

MEDP:

0.88

FNV:

0.63

PS Ratio

MEDP:

5.04

FNV:

19.71

PB Ratio

MEDP:

22.17

FNV:

5.10

Total Revenue (TTM)

MEDP:

$2.68B

FNV:

$2.10B

Gross Profit (TTM)

MEDP:

$778.59M

FNV:

$1.61B

EBITDA (TTM)

MEDP:

$572.96M

FNV:

$1.96B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MEDP vs. FNV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MEDP
MEDP Risk / Return Rank: 7373
Overall Rank
MEDP Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
MEDP Sortino Ratio Rank: 7373
Sortino Ratio Rank
MEDP Omega Ratio Rank: 8282
Omega Ratio Rank
MEDP Calmar Ratio Rank: 7070
Calmar Ratio Rank
MEDP Martin Ratio Rank: 6969
Martin Ratio Rank

FNV
FNV Risk / Return Rank: 6565
Overall Rank
FNV Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
FNV Sortino Ratio Rank: 6060
Sortino Ratio Rank
FNV Omega Ratio Rank: 6262
Omega Ratio Rank
FNV Calmar Ratio Rank: 6767
Calmar Ratio Rank
FNV Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MEDP vs. FNV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Medpace Holdings, Inc. (MEDP) and Franco-Nevada Corporation (FNV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MEDPFNVDifference
Sharpe ratioReturn per unit of total volatility

-0.03

Sortino ratioReturn per unit of downside risk

+0.64

Omega ratioGain probability vs. loss probability

1.32

1.17

+0.15

Calmar ratioReturn relative to maximum drawdown

1.49

1.26

+0.23

Martin ratioReturn relative to average drawdown

3.38

3.00

+0.38

MEDP vs. FNV - Sharpe Ratio Comparison

The current MEDP Sharpe Ratio is 0.79, which is comparable to the FNV Sharpe Ratio of 0.82. The chart below compares the historical Sharpe Ratios of MEDP and FNV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


MEDPFNVDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.79

0.82

-0.03

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.43

0.26

+0.16

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.43

Sharpe Ratio (All Time)

Calculated using the full available price history

0.67

0.45

+0.22

Drawdowns

MEDP vs. FNV - Drawdown Comparison

The maximum MEDP drawdown since its inception was -42.87%, smaller than the maximum FNV drawdown of -58.76%. Use the drawdown chart below to compare losses from any high point for MEDP and FNV.


Loading charts...

Drawdown Indicators


MEDPFNVDifference

Max Drawdown

Largest peak-to-trough decline

-42.87%

-58.76%

+15.89%

Max Drawdown (1Y)

Largest decline over 1 year

-36.61%

-23.40%

-13.21%

Max Drawdown (3Y)

Largest decline over 3 years

-39.38%

-29.64%

-9.74%

Max Drawdown (5Y)

Largest decline over 5 years

-42.87%

-37.12%

-5.75%

Max Drawdown (10Y)

Largest decline over 10 years

-37.12%

Current Drawdown

Current decline from peak

-26.22%

-23.40%

-2.82%

Average Drawdown

Average peak-to-trough decline

-12.91%

-13.96%

+1.05%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.16%

9.83%

+6.33%

Volatility

MEDP vs. FNV - Volatility Comparison

The current volatility for Medpace Holdings, Inc. (MEDP) is 6.61%, while Franco-Nevada Corporation (FNV) has a volatility of 12.49%. This indicates that MEDP experiences smaller price fluctuations and is considered to be less risky than FNV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MEDPFNVDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.61%

12.49%

-5.88%

Volatility (6M)

Calculated over the trailing 6-month period

37.78%

30.10%

+7.68%

Volatility (1Y)

Calculated over the trailing 1-year period

69.11%

36.00%

+33.11%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

51.61%

30.35%

+21.26%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.80%

30.18%

+19.62%

Dividends

MEDP vs. FNV - Dividend Comparison

MEDP has not paid dividends to shareholders, while FNV's dividend yield for the trailing twelve months is around 0.74%.


PositionTTM20252024202320222021202020192018201720162015
FNV
Franco-Nevada Corporation
0.74%0.73%1.22%1.23%0.94%1.10%0.82%0.96%1.35%1.14%1.46%1.81%
MEDP
Medpace Holdings, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

MEDP vs. FNV - Financials Comparison

This section allows you to compare key financial metrics between Medpace Holdings, Inc. and Franco-Nevada Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


300.00M400.00M500.00M600.00M700.00M20222023202420252026
706.60M
641.09M
(MEDP) Total Revenue
(FNV) Total Revenue
Values in USD except per share items

MEDP vs. FNV - Profitability Comparison

The chart below illustrates the profitability comparison between Medpace Holdings, Inc. and Franco-Nevada Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%20222023202420252026
27.8%
80.9%
Portfolio components
MEDP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported a gross profit of 196.33M and revenue of 706.60M. Therefore, the gross margin over that period was 27.8%.

FNV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Franco-Nevada Corporation reported a gross profit of 518.42M and revenue of 641.09M. Therefore, the gross margin over that period was 80.9%.

MEDP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported an operating income of 141.50M and revenue of 706.60M, resulting in an operating margin of 20.0%.

FNV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Franco-Nevada Corporation reported an operating income of 503.23M and revenue of 641.09M, resulting in an operating margin of 78.5%.

MEDP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported a net income of 123.87M and revenue of 706.60M, resulting in a net margin of 17.5%.

FNV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Franco-Nevada Corporation reported a net income of 462.11M and revenue of 641.09M, resulting in a net margin of 72.1%.


Frequently Asked Questions


MEDP and FNV have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FNV has higher volatility (12.49%) compared to MEDP (6.61%). In terms of maximum drawdown, MEDP dropped -42.87% vs FNV's -58.76%.

FNV currently has the higher Sharpe Ratio (0.82 vs 0.79), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MEDP and FNV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer